ICUI Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
560.4M
+1.6%
551.7M
+4.0%
530.2M
-1.9%
540.7M
+0.7%
537.0M
Cost of Revenue
325.7M
+2.9%
316.6M
-2.3%
324.0M
-4.1%
337.7M
+0.5%
336.1M
Gross Profit
234.8M
-0.1%
235.1M
+14.0%
206.2M
+1.6%
203.0M
+1.0%
200.9M
Operating Expenses
182.4M
-6.9%
195.9M
+1.7%
192.6M
-2.4%
197.3M
+5.4%
187.2M
R&D
21.8M
-4.2%
22.7M
+6.7%
21.3M
+0.9%
21.1M
-0.8%
21.3M
SG&A
154.4M
+1.6%
151.9M
-1.7%
154.6M
-0.8%
155.8M
+2.0%
152.8M
Operating Income
52.3M
+33.7%
39.1M
+188.1%
13.6M
+141.0%
5.6M
-58.9%
13.7M
EBITDA
108.2M
-1.7%
110.0M
+36.9%
80.4M
+4.5%
76.9M
-1.0%
77.7M
Net Income
26.8M
+40.7%
19.1M
-36.7%
30.1M
+291.5%
-15734000
-363.3%
-3396000
EPS (Basic)
$1.07
+40.8%
$0.76
-37.7%
$1.22
+290.6%
$-0.64
-357.1%
$-0.14
EPS (Diluted)
$1.07
+40.8%
$0.76
-36.7%
$1.20
+296.7%
$-0.61
-335.7%
$-0.14
Shares (Diluted)
25.1M
+0.4%
25.0M
-0.5%
25.2M
-2.0%
25.7M
+4.0%
24.7M
ICU Medical (ICUI) — Financials